Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California
- 5 April 2019
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 23 (10) , 2730-2740
Abstract
We conducted a records-based cohort study of patients who initiated pre-exposure prophylaxis (PrEP) at a large federally qualified health center in Los Angeles, CA to characterize patterns of PrEP use, identify correlates of PrEP discontinuation, and calculate HIV incidence. Of 3121 individuals initiating PrEP between 2014 and 2017, 42% (n = 1314) were active (i.e., had a current PrEP prescription) in April 2018. HIV incidence was 0.1/100 person-years among active PrEP patients, compared to 2.1/100 person-years among patients who discontinued. Compared to patients accessing PrEP through government programs with no prescription copay, risk of discontinuation was higher among those with private insurance (ARR = 1.4, 95% CI 1.2, 1.7), or no insurance (ARR = 4.5, 95% CI 3.2, 6.4). Sixty-three percent of active PrEP patients had gaps between PrEP prescriptions, averaging one gap per year (median length = 65 days). Increasing access to free or low-cost PrEP can improve PrEP continuity.Keywords
Funding Information
- National Institute of Mental Health (T32MH080634, P30 MH058107)
- National Institute of Allergy and Infectious Diseases (K01AI091861)
- National Institute on Drug Abuse (DA035165)
This publication has 23 references indexed in Scilit:
- HIV Preexposure Prophylaxis Initiation at a Large Community Clinic: Differences Between Eligibility, Awareness, and UptakeAmerican Journal of Public Health, 2018
- Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling StudyJournal of Adolescent Health, 2018
- Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012–2017: Are Quarterly Visits Too Much?Clinical Infectious Diseases, 2018
- HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health ClinicAIDS and Behavior, 2017
- An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSMJAIDS Journal of Acquired Immune Deficiency Syndromes, 2017
- Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and DiscontinuationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Retention in care outcomes for HIV pre‐exposure prophylaxis implementation programmes among men who have sex with men in three US citiesJournal of the International AIDS Society, 2016
- Sexual Risk Trajectories Among MSM in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with MenScience Translational Medicine, 2012
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010